Combining optoacoustic imaging phenotypes and multi-omics to advance diabetes healthcare

akronüüm: OPTOMICS
algus: 2021-01-01
lõpp: 2025-12-31
 
programm: H2020 - Horisont 2020
alaprogramm: FET - Tulevased ja kujunemisjärgus tehnoloogiad
instrument: RIA
projektikonkurss: H2020-FETPROACT-2020-2
projekti number: 101017802
kestus kuudes: 60
partnerite arv: 6
 
lühikokkuvõte: Diabetes has emerged as a global pandemic affecting more than 420 million people worldwide, a number expected to further rise in the next decades. The disease has very heterogeneous outcomes and accurate patient staging or prediction of subsets of individ
partneri jrk nr ja roll partneri nimi riik kontaktisik koduleht
1 koordinaator TECHNISCHE UNIVERSITAET MUENCHEN DE Vasilis NTZIACHRISTOS www.tum.de
2 partner TARTU ULIKOOL EE www.ut.ee
3 partner TATAA BIOCENTER AB SE
4 partner NIGHTINGALE HEALTH OY FI
5 partner RAYFOS LTD UK www.rayfos.com
6 partner HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH DE www.helmholtz-muenchen.de